Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeBIOTECHNOLOGYCytoSMART Launches Its 1st Fluorescence Live-cell Imaging Microscope

CytoSMART Launches Its 1st Fluorescence Live-cell Imaging Microscope

November 3, 2020

CytoSMART Technologies today announced its first fluorescence live-cell imager. The CytoSMART Lux3 FL is a small live-cell imaging microscope equipped with one brightfield and two fluorescent channels (green and red).

CytoSMART notes the device enables researchers to unravel cellular processes in real-time, while the cells are kept in a controlled environment inside a standard cell culture incubator.

CytoSMART states their first fluorescence live-cell imager allows users to track dynamic cellular processes with high specificity by taking high-quality images to create real-time time-lapse movies.


Said Jan-Willem van Bree, CTO at CytoSMART Technologies, “Currently, fluorescent labeling is mostly used as an end-point measurement. However, time-lapse imaging of live cells can give much more information about biological processes. By using automated imaging at regular time intervals, the temporal resolution of the fluorescent data is increased, leading to even more relevant data about the cellular processes.

In this way, researchers can not only determine if a certain process has occurred, but also when it occurred and at what speed. Our customers have been asking us to develop a small and easy-to-use microscope with integrated image analysis of bright-field and fluorescence data. We have listened and made it happen.”

The main features and benefits of the CytoSMART Lux3 FL include:

  • Integrated image analysis of bright-field and fluorescence area or fluorescence object count.
  • Time-lapse movies to investigate the development of cellular processes.
  • Expanded number of variables researchers can analyze in their cell culture using green and red fluorescence.
  • Remote data accessibility via the CytoSMART Cloud with a smartphone, tablet, or laptop outside the lab.
  • Portable, easy-to-use, and incubator friendly live-cell imager.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy